integrin-ecm-signaling-cbs-psp

integrin-ecm-signaling-cbs-psp

Overview

Integrin-extracellular matrix (ECM) signaling represents a critical cell-substrate communication pathway that regulates cellular adhesion, migration, and immune activation. In the context of corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP)—two primary tauopathies characterized by abnormal tau protein accumulation—dysregulation of integrin-ECM interactions has emerged as a significant contributor to neuroinflammatory pathology. The integrin-vitronectin axis, in particular, plays a central role in microglial activation and dysfunction within these neurodegenerative conditions, leading to impaired tau clearance and perpetuation of neuroinflammatory cascades.

Function/Biology

Integrins are heterodimeric transmembrane receptors composed of α and β subunits that mediate cell-ECM interactions and cell-cell contacts. The αvβ3 integrin, one of the most broadly expressed integrin heterodimers, serves as a primary receptor for multiple ECM ligands, including vitronectin, fibrinogen, and von Willebrand factor. Vitronectin is a 75-kDa glycoprotein present in blood plasma and the ECM that promotes cell adhesion, spreading, and migration through integrin binding.

integrin-ecm-signaling-cbs-psp

Overview

Integrin-extracellular matrix (ECM) signaling represents a critical cell-substrate communication pathway that regulates cellular adhesion, migration, and immune activation. In the context of corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP)—two primary tauopathies characterized by abnormal tau protein accumulation—dysregulation of integrin-ECM interactions has emerged as a significant contributor to neuroinflammatory pathology. The integrin-vitronectin axis, in particular, plays a central role in microglial activation and dysfunction within these neurodegenerative conditions, leading to impaired tau clearance and perpetuation of neuroinflammatory cascades.

Function/Biology

Integrins are heterodimeric transmembrane receptors composed of α and β subunits that mediate cell-ECM interactions and cell-cell contacts. The αvβ3 integrin, one of the most broadly expressed integrin heterodimers, serves as a primary receptor for multiple ECM ligands, including vitronectin, fibrinogen, and von Willebrand factor. Vitronectin is a 75-kDa glycoprotein present in blood plasma and the ECM that promotes cell adhesion, spreading, and migration through integrin binding.

In the central nervous system (CNS), integrins are expressed on multiple cell types, including neurons, glia, and endothelial cells. Microglial cells express various integrin combinations, with αvβ3 representing an important subset. Through integrin engagement with ECM ligands, cells receive signals that modulate cytoskeletal organization, activate intracellular signaling cascades, and influence gene expression. The interaction between integrin cytoplasmic domains and focal adhesion proteins such as focal adhesion kinase (FAK), talin, and paxillin initiates downstream phosphorylation cascades that propagate cellular responses.

Role in Neurodegeneration

In CBS and PSP, the integrin-vitronectin axis becomes pathologically dysregulated. Recent single-cell transcriptomic analyses have demonstrated that microglial populations in these tauopathies exhibit significant upregulation of αvβ3 integrin expression compared to control brain tissue. This enhanced expression correlates with increased vitronectin abundance in affected brain regions, establishing an amplified integrin-ECM signaling loop.

The pathological significance of this dysregulation lies in its interference with microglial phagocytic function. Rather than facilitating effective tau clearance, enhanced αvβ3-vitronectin engagement promotes a pro-inflammatory microglial phenotype characterized by elevated production of cytokines and chemokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), and interleukin-6 (IL-6). This shift toward pro-inflammatory activation paradoxically reduces microglial capacity to phagocytose and degrade tau aggregates, perpetuating accumulation of pathological tau within the brain.

Molecular Mechanisms

The molecular basis of integrin-mediated microglial dysfunction in tauopathies involves several interconnected pathways. Vitronectin binding to αvβ3 integrins activates focal adhesion kinase (FAK) and Src family kinases, leading to downstream activation of PI3K/Akt and MAPK/ERK signaling cascades. These pathways promote pro-inflammatory gene transcription through NF-κB and STAT3 activation, increasing production of chemokines and cytokines.

Additionally, αvβ3-vitronectin engagement may impair the functional expression of other microglial receptors critical for tau phagocytosis, including triggering receptor expressed on myeloid cells 2 (TREM2) and complement receptor 3 (CR3). The integrin signaling-induced pro-inflammatory state also increases reactive oxygen species (ROS) production through NADPH oxidase activation, further exacerbating neuronal damage and tau pathology.

Clinical/Research Significance

Understanding integrin-ECM signaling dysregulation in CBS and PSP has direct therapeutic implications. Blocking the αvβ3-vitronectin interaction through specific integrin antagonists or function-blocking monoclonal antibodies represents a potential therapeutic strategy to restore microglial phagocytic capacity and reduce neuroinflammation. Such approaches could enhance endogenous tau clearance while simultaneously reducing pro-inflammatory cytokine production, potentially slowing disease progression.

Current research efforts focus on characterizing integrin-ECM dysregulation across different microglial subpopulations in tauopathies and identifying biomarkers that predict therapeutic response to integrin-targeted interventions.

Related Entities

• αvβ3 Integrin: Primary receptor mediating pathological vitronectin signaling in tauopathy microglia
• Vitronectin: ECM ligand driving pro-inflammatory microglial activation
• Focal Adhesion Kinase (FAK): Downstream signaling mediator of integrin activation
• Microglial Phagocytosis: Target process impaired by dysreg

Pathway Diagram

The following diagram shows the key molecular relationships involving integrin-ecm-signaling-cbs-psp discovered through SciDEX knowledge graph analysis: